An initiative to manufacture and characterize baculovirus reference material

Journal of Invertebrate Pathology

Volumn 107, Issue SUPPL., 2011, Pages

  Kamen, Amine A ^a   Aucoin, Marc G ^b   Merten, Otto Wilhelm ^c   Alves, Paula ^d   Hashimoto, Yoshifumi ^e   Airenne, Kari ^f   Hu, Yu Chen ^g   Mezzina, Mauro ^h   van Oers, Monique M ⁱ  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

^c GÉNÉTHON   (France)

^d Instituto de Biologia Experimental Technologica   (Portugal)

^e Protein Sciences Corp   (United States)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^h CNRS   (France)

ⁱ WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Baculovirus expression; Gene therapy; Reference material; Standard; Vaccine

Indexed keywords

BIOLOGICAL PRODUCT; RECOMBINANT VACCINE;

BACULOVIRUS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETIC ENGINEERING; GENETICS; HUMAN; LETTER; METHODOLOGY; PHARMACEUTICS; QUALITY CONTROL; STANDARD;

BACULOVIRIDAE; BIOLOGICAL AGENTS; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; QUALITY CONTROL; REFERENCE STANDARDS; TECHNOLOGY, PHARMACEUTICAL; VACCINES, SYNTHETIC;

EID: 79960645277     PISSN: 00222011     EISSN: 10960805     Source Type: Journal    
DOI: 10.1016/j.jip.2011.02.007     Document Type: Letter

References (45)

1. Aucoin M.G., Mena J.A., Kamen A.A. Bioprocessing of baculovirus vectors: a review. Curr. Gene Ther. 2010, 10:174-186.
2. Aucoin M.G., Perrier M., Kamen A.A. Critical assessment of current adeno-associated viral vector production and quantification methods. Biotechnol. Adv. 2008, 26:73-88.
3. Ayres M.D., Howard S.C., Kuzio J., Lopez-Ferber M., Possee R.D. The complete DNA sequence of Autographa californica nuclear polyhedrosis virus. Virology 1994, 202:586-605.
4. Chan Z.R., Lai C.W., Lee H.P., Chen H.C., Hu Y.C. Determination of the baculovirus transducing titer in mammalian cells. Biotechnol. Bioeng. 2006, 93:564-571.
5. Cohen D.P.A., Marek M., Davies B.G., Vlak J.M., van Oers M.M. Encyclopedia of Autographa californica nucleopolyhedrovirus genes. Virol. Sin. 2009, 24:359-414.
6. Cox M.M.J., Hashimoto Y. A fast track influenza virus vaccine produced in insect cells. J. Invertebr. Pathol. 2011, 107:S31.
7. De Gooijer C.D., Koken R.H., Van Lier F.L., Kool M., Vlak J.M., Tramper J. A structured dynamic model for the baculovirus infection process in insect-cell reactor configurations. Biotechnol. Bioeng. 1992, 40:537-548.
8. Ferris, M.M., Stepp, P.C., Ranno, K.A., Mahmoud, W., Ibbitson, E., Jarvis, J., Cox, M.M., Christensen, K., Votaw, H., Edwards, D.P., Rowlen, K.L., in press. Evaluation of the virus counter® for rapid baculovirus quantitation. J. Virol. Methods.
9. Hitchman R.B., Siaterli E.A., Nixon C.P., King L.A. Quantitative real-time PCR for rapid and accurate titration of recombinant baculovirus particles. Biotechnol. Bioeng. 2007, 96:810-814.
10. Hofmann C., Sandig V., Jennings G., Rudolph M., Schlag P., Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. 1995, 92:10099-10103.
11. Hu Y.-C., Tsai C.-T., Chung Y.-C., Lu J.-T., Hsu T.-A. Generation of chimeric baculovirus with histidine-tags displayed on the envelope and its purification using immobilized metal affinity chromatography. Enzyme Microb. Technol. 2003, 33:445-452.
12. Hu Y.C. Baculovirus: a promising vector for gene therapy?. Curr. Gene Ther. 2010, 10:167.
13. Hu Y.C., Tsai C.T., Chang Y.J., Huang J.H. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol. Prog. 2003, 19:373-379.
14. Hutchins B., Sajjadi N., Seaver S., Shepherd A., Bauer S.R., Simek S., Carson K., Aguilar-Cordova E. Working toward an adenoviral vector testing standard. Mol. Ther. 2000, 2:532-534.
15. Jehle J.A., Blissard G.W., Bonning B.C., Cory J.S., Herniou E.A., Rohrmann G.F., Theilmann D.A., Thiem S.M., Vlak J.M. On the classification and nomenclature of baculoviruses: a proposal for revision. Arch. Virol. 2006, 151:1257-1266.
16. Jorio H., Tran R., Kamen A. Stability of serum-free and purified baculovirus stocks under various storage conditions. Biotechnol. Prog. 2006, 22:319-325.
17. Kantoff P.W., Higano C.S., Shore N.D., Berger E.R., Small E.J., Penson D.F., Redfern C.H., Ferrari A.C., Dreicer R., Sims R.B., et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 2010, 363:411-422.
18. King L.K., Possee R.D. The Baculovirus Expression System: a Laboratory Guide 1992, Chapman and Hall, London.
19. Kool M., Voncken J.W., van Lier F.L., Tramper J., Vlak J.M. Detection and analysis of Autographa californica nuclear polyhedrosis virus mutants with defective interfering properties. Virology 1991, 183:739-746.
20. Kost T.A., Condreay J.P., Jarvis D.L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol. 2005, 23:567-575.
21. Krell P.J. Passage Effect of Virus Infection in Insect Cells. In: Insect Cell Cultures, Fundamental and Applied Aspects 1996, Kluwer, Dordrecht, the Netherlands, pp. 125-137.
22. Lo H.R., Chao Y.C. Rapid titer determination of baculovirus by quantitative real-time polymerase chain reaction. Biotechnol. Prog. 2004, 20:354-360.
23. Lock M., McGorray S., Auricchio A., Ayuso E., Beecham E.J., Blouin-Tavel V., Bosch F., Bose M., Byrne B.J., Caton T., et al. Characterization of a recombinant adeno-associated virus type 2 reference standard material. Hum. Gene Ther. 2010, 21:1273-1285.
24. Luckow V.A., Lee S.C., Barry G.F., Olins P.O. Efficient generation of infectious recombinant baculoviruses by site- specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J. Virol. 1993, 67:4566-4579.
25. Lynn D.E. Improved efficiency in determining the titer of the Autographa californica baculovirus nonoccluded virus. Biotechniques 1992, 13:282-285.
26. Madhan S., Prabakaran M., Kwang J. Baculovirus as vaccine vectors. Curr. Gene Ther. 2010, 10:201-213.
27. Mena, J.A., Kamen, A.A., 2011. Insect cell technology is a versatile and robust vaccine manufacturing platform. Expert Opinion in Vaccines (in press).
28. Mena J.A., Ramirez O.T., Palomares L.A. Titration of non-occluded baculovirus using a cell viability assay. Biotechniques 2003, 34:260-262. 264.
29. O'Reilly D.R., Miller L.K., Luckow V.A. Baculovirus Expression Vectors: a Laboratory Manual 1992, W.H. Freeman and Company, New York.
30. Pijlman G.P., Dortmans J.C., Vermeesch A.M., Yang K., Martens D.E., Goldbach R.W., Vlak J.M. Pivotal role of the non-hr origin of DNA replication in the genesis of defective interfering baculoviruses. J. Virol. 2002, 76:5605-5611.
31. Pijlman G.P., Van Schijndel J.E., Vlak J.M. Spontaneous excision of BAC vector sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells. J. Gen. Virol. 2003, 84:2669-2678.
32. Pouliquen Y., Kolbinger F., Geisse S., Mahnke M. Automated baculovirus titration assay based on viable cell growth monitoring using a colorimetric indicator. Biotechniques 2006, 40:282-292.
33. Rohrmann, G.F. 2008. Baculovirus Molecular Biology, Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information.
34. Roldao A., Oliveira R., Carrondo M.J., Alves P.M. Error assessment in recombinant baculovirus titration: evaluation of different methods. J. Virol. Methods 2009, 159:69-80.
35. Shen C.F., Meghrous J., Kamen A. Quantitation of baculovirus particles by flow cytometry. J. Virol. Methods 2002, 105:321-330.
36. Transfiguracion J., Jorio H., Meghrous J., Jacob D., Kamen A. High yield purification of functional baculovirus vectors by size exclusion chromatography. J. Virol. Methods 2007, 142:21-28.
37. Transfiguracion J., Mena J.A., Aucoin M.G., Kamen A.A. Development and validation of a HPLC method for the quantification of baculovirus particles. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010.
38. Urabe M., Ding C., Kotin R.M. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 2002, 13:1935-1943.
39. Vail P.V., Sutter G., Jay D.L., Gough D. Reciprocal infectivity of nuclear polyhedrosis viruses of the cabbage looper and alfalfa looper. J. Invertebr. Pathol. 1971, 17:383-388.
40. van Oers M.M. Vaccines for viral and parasitic diseases produced with baculovirus vectors. Adv. Virus Res. 2006, 68:193-253.
41. van Oers M.M. Opportunities and challenges for the baculovirus expression system. J. Invertebr. Pathol. 2011, 107:S3.
42. Vaughn J.L., Goodwin R.H., Tompkins G.J., McCawley P. The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera; Noctuidae). In Vitro 1977, 13:213-217.
43. Vicente T., Peixoto C., Carrondo M.J., Alves P.M. Purification of recombinant baculoviruses for gene therapy using membrane processes. Gene Ther. 2009, 16:766-775.
44. Wu C., Soh K.Y., Wang S. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum. Gene Ther. 2007, 18:665-672.
45. Zwart M.P., van Oers M.M., Cory J.S., van Lent J.W., van der Werf W., Vlak J.M. Development of a quantitative real-time PCR for determination of genotype frequencies for studies in baculovirus population biology. J. Virol. Methods 2008, 148:146-154.